Arkolith/Insider Trading/BSTG/Form 4

Chen Jing

DirectorBiostage, Inc. (BSTG) · full profile →Form 4 · filed Dec 9, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$348K
Net Open-Market Flow
-$348K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 7, 2022Sell(S)49K$7.17$348K161K
Dec 7, 2022Option exercise(X)174K$2.00$348K210K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 7, 2022Option exercise(X)174K—$00

Transaction Codes

S
Open-market sale
X
Exercise of in-the-money derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-22-012347) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML